EXAS vs FIVE · rev $2.76B vs P/E 28, rev $1.39B
EXACT Sciences Corporation (EXAS) versus Five Below Inc (FIVE) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
EXAS currently screens at market cap $20.03B. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Not investment advice. Open the EXAS and FIVE stock pages for the full models.
Not investment advice.